Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurotoxicity Syndromes × neurotropin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neurotoxicity Syndromes 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 4 Leucovorin 3 Fluorouracil 3 xaliproden 2 Folfox protocol 2 neurotropin 1 Sodium Chloride 1 Pharmacogenomic Testing 1 Magnesium Sulfate 1 Gene Expression Profiling 1 Capecitabine 1 Calcium Gluconate 1 Bevacizumab 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07320950 2026-01-06

Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients

Sun Yat-sen University

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡